Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Marty D. Pagel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8109-3995; OpenAlex author ID A5110179615. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 6

  1. Multiparametric MRI to Predict Response to Irreversible Electroporation Plus Anti-PD-1 Immunotherapy in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1002/mrm.70188↗
  2. Machine learning improves classification of preclinical models of pancreatic cancer with chemical exchange saturation transfer MRI. Last author DOI 10.1002/mrm.27439↗
  3. Extracellular acidosis differentiates pancreatitis and pancreatic cancer in mouse models using acidoCEST MRI. Last author DOI 10.1016/j.neo.2019.09.004↗
  4. Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [18F]FDG PET and acidoCEST MRI. Last author DOI 10.1007/s11307-018-1164-4↗
  5. Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor. Last author DOI 10.1097/mpa.0000000000000607↗
  6. Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer. Co-author DOI 10.2147/ijn.s68511↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julio Cárdenas‐Rodríguez · 2 shared papers, 2018–2019 · strength 0.30
  2. Joshua M. Goldenberg · 2 shared papers, 2018–2019 · strength 0.30
  3. Qizhen Cao · 1 shared paper, 2026 · strength 0.29
  4. Sanaz Javadi · 1 shared paper, 2026 · strength 0.29
  5. Chun Li · 1 shared paper, 2026 · strength 0.29
  6. Rachel A. High · 1 shared paper, 2019 · strength 0.10
  7. Joseph E. Kobes · 1 shared paper, 2016 · strength 0.07
  8. Armando Lucero‐Acuña · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.